Enhancement of glycated chitosan in laser cancer treatment

Proceedings of SPIE - The International Society for Optical Engineering

Volumn 5319, Issue , 2004, Pages 80-86

  Chen, Wei R ^a   Jeong, Sang Won ^a   Korbelik, Mladen ^b   Bartels, Kenneth E ^c   Martin, Steven D ^c   Sun, Jinghai ^b   Liu, Hong ^d   Nordquist, Robert E ^e  

^a UNIVERSITY OF CENTRAL OKLAHOMA   (United States)

^b BRITISH COLUMBIA CANCER AGENCY   (Canada)

^c OKLAHOMA STATE UNIVERSITY   (United States)

^d University of Oklahoma   (United States)

^e Wound Healing of Oklahoma   (United States)

Author keywords

B16 melanoma; EMT6 mammary sarcoma; Glycated chitosan; Line 1 lung adenocarcinoma; Metastatic tumors; Photodynamic therapy

Indexed keywords

ANTIGENS; CARCINOGENS; DIAGNOSTIC PRODUCTS; HEALTH CARE; IMMUNOLOGY; LASER BEAM EFFECTS; LASER DIAGNOSTICS; PHOTODYNAMIC THERAPY; TUMORS;

B16 MELANOMA; EMT6 MAMMARY SARCOMA; GLYCATED CHITOSAN (GC); LINE-1 LUNG ADENOCARCINOMA; METASTATIC TUMORS;

DISEASES;

EID: 5644226266     PISSN: 0277786X     EISSN: None     Source Type: Conference Proceeding    
DOI: 10.1117/12.530577     Document Type: Conference Paper

References (18)

1. W. R. Chen, R. L. Adams and R. E. Nordquist, Laser-photosensitizer assisted immunotherapy: A novel modality in cancer treatment. Cancer Letters, 115:25-30, 1997.
2. W. R. Chen, R. Carubelli, H. Liu and R. E. Nordquist, Laser immunotherapy: A Novel Treatment Modality for Metastatic Tumors. Molecular Biotechnology, 25, 37-43, 2003.
3. W. R. Chen, W.-G. Zhu, J. R. Dynlacht, H. Liu and R..E. Nordquist, Long-term tumor resistance induced by laser photo-immunotherapy. International Journal of Cancer, 81, 808-812, 1999.
4. W. R. Chen, A. K. Singhal, H. Liu and R. E. Nordquist, Laser immunotherapy induced antitumor immunity and its adoptive transfer. Cancer Research, 61, 459-461, 2001.
5. W. R. Chen, J. W. Ritchey, K. E. Bartels, H. Liu and R. E. Nordquist, Effect of different components of laser immunotherapy in treatment of metastatic tumors in rats. Cancer Research, 62, 4295-4299, 2002.
6. W. R. Chen, S. W. Jeong, M. D. Lucroy, R. F. Wolf, H. Liu and R. E. Nordquist, Induced anti-tumor immunity against DMBA-4 metastatic mammary tumors in rats using a novel approach. International Journal of Cancer, 107 (6), 1053-1057, 2003.
7. T. J. Dougherty, J. E. Kaufman, A. Goldfarb, K. R. Weishaupt, D. G. Boyle and A. Mittleman, Photoradiation therapy for the treatment of malignant tumors. Cancer Research, 38, 2628-2635, 1978.
8. M. J. Manyak, A. Russo, P. D. Smith, and E. Glatsein, Photodynamic therapy. Journal of Clinical Oncology, 6, 380-391, 1988.
9. A. Dahlman, Laser photoradiation therapy of cancer. Cancer Research, 43, 430-434, 1983.
10. A. Fisher, L. Murphee, and C. J. Gomer, Clinical and pre-clinical photodynamic therapy. Lasers in Surgery and Medicine, 17, 2-31, 1995.
11. K. R. Weishaupt, C. J. Gomer and T. J. Dougherty, Identification of singlet oxygen as the cytotoxic agent in photodynamic inactivation of a murine tumor. Cancer Research, 36, 2326-2329, 1979.
12. B. W. Henderson and T. J. Dougherty, How does photodynamic therapy work? Photochemistry and Photobiology, 55, 145-157, 1992.
13. R. Davis, Effects of photosensitizer (Hematoporphyrin derivative-HPD) and light dose on vascular targets in albino mouse ear. Laryngoscope, 98, 1-4, 1988.
14. J. Nelson, Tumor destruction in photodynamic therapy. Photochemistry and Photobiology, 46, 829-835, 1987.
15. H. I. Pass, Photodynamic therapy in oncology: mechanisms and clinical use. Journal of National Cancer Institute, 85, 443-456, 1993.
16. S.C. Rockwell, R.F. Kallman and L.F. Fajardo, Characteristics of a serially transplanted mouse mammary tumour and its tissue-culture-adapted derivative. J. Natl. Cancer Inst. 49: 735-749, 1972.
17. J. M. Yuhas, N.H. Pazmino, J.O. Proctor and R.E. Toya, A direct relationship between immune competence and the subcutaneous growth rate of a malignant murine lung tumor. Cancer Res. 34: 722-728, 1974.
18. K. Nakamura, N. Yoshikawa, Y. Yamaguchi, S. Kagota, K. Shinozuka, M. Kunitomo, Characterization of mouse melanoma cell lines by their mortal malignancy using an experimental metastatic model. Life Sciences, 70, 791-798, 2002.